Tatva Chintan Pharma Chem reported a strong second quarter for FY27, with consolidated revenue rising 76% to Rs 217.32 crore and net profit surging 116% to Rs 21.45 crore compared to the same period last year. The robust performance highlights a significant growth trajectory, though investors are advised to track working capital trends and ongoing capital expenditure projects to gauge future sustainability.
Tatva Chintan Reports Strong Q2 Growth With 116% Profit Surge
Consolidated Revenue: Rs 217.32 crore | Net Profit: Rs 21.45 crore
Reader Takeaway: Strong top-line and bottom-line expansion signals operational momentum; investors must monitor cash flow and capacity utilization.
What just happened
Tatva Chintan Pharma Chem Ltd has posted its financial results for the quarter ended 30 September 2026. The company delivered a significant year-over-year improvement, with consolidated revenue from operations climbing to Rs 217.32 crore from Rs 123.52 crore. Consolidated net profit rose to Rs 21.45 crore, compared to Rs 9.92 crore in the corresponding quarter of the previous year. The basic earnings per share (EPS) also saw a sharp increase, reaching Rs 9.17 for the quarter.
Why this matters
The company’s performance highlights a successful scaling of operations. On a standalone basis, revenue hit Rs 207.48 crore, further confirming that core business segments are contributing heavily to the bottom line. With an unmodified audit report from M/s. NDJ & Co., the financial reporting remains clean, providing confidence to market participants regarding the authenticity of the growth metrics.
Risks to watch
While profitability is up, cash flow dynamics bear watching. For the half-year ended 30 September 2026, the company recorded net cash used in operating activities (after taxes) at Rs 3.68 crore. Future capital expenditure in property, plant, and equipment remains high, and shareholders should monitor how effectively these investments convert into sustained operational cash flows in upcoming quarters.
What to track next
Investors should focus on capacity utilization levels as the company scales its infrastructure. Furthermore, maintaining profit margins amid potential fluctuations in input costs will be critical to sustaining the current growth momentum observed in this half-year performance.